Skip to main content

Table 3 Clinical information of patients providing urinary samples included for 2-DE analysis

From: Identification of Apo-A1 as a biomarker for early diagnosis of bladder transitional cell carcinoma

No.

Age

Sex

Grade

Two-tie grading system

No.

Age

Sex

Condition

1

57

F

G2

I

41

56

M

chronic inflammation of bladder

2

55

M

G2

I

42

57

F

chronic inflammation of bladder

3

65

M

G1

I

43

66

M

chronic inflammation of bladder

4

64

M

G2

I

44

65

F

bladder atypia hyperplasy

5

69

F

G2

I

45

70

M

bladder atypia hyperplasy

6

66

M

G2

I

46

61

M

bladder atypia hyperplasy

7

67

F

G2

I

47

67

M

bladder atypia hyperplasy

8

75

F

G2

I

48

65

M

inverted papilloma of bladder

9

51

M

G1

I

49

50

F

normal

10

69

F

G1

I

50

53

F

normal

11

60

M

G1

I

51

56

F

normal

12

62

M

G1

I

52

58

F

normal

13

60

M

G2

I

53

70

M

normal

14

61

M

G2

I

54

72

M

normal

15

69

M

G2

I

55

61

M

normal

16

67

F

G1- G2

I

56

67

M

normal

17

61

M

G2

I

57

59

M

normal

18

79

M

G2

I

58

73

M

normal

19

61

M

G1- G2

I

59

75

M

normal

20

59

F

G2

I

60

64

M

normal

21

54

M

G2

I

61

58

M

normal

22

48

M

G2

I

62

52

M

normal

23

56

M

G1- G2

I

63

72

M

normal

24

57

F

G2

I

64

51

M

normal

25

71

F

G2-G3

II

65

50

M

normal

26

80

F

G2-G3

II

66

57

F

normal

27

76

M

G3

II

67

63

F

normal

28

53

M

G3

II

68

65

F

normal

29

52

M

G3

II

69

54

F

normal

30

59

M

G3

II

70

58

F

normal

31

69

M

G3

II

71

77

F

normal

32

60

M

G3

II

72

66

M

normal

33

58

M

G3

II

    

34

39

M

G3

II

    

35

80

M

G3

II

    

36

55

M

G3

II

    

37

68

M

G3

II

    

38

72

M

G3

II

    

39

77

M

G3

II

    

40

59

M

G3

II

    
  1. I: Low Malignant BTCC; II: Aggressive BTCC